The colour of the lines on the chart indicate the performance of the rating based upon the price at the point the rating was submitted. More information »
BUY KIE by
Price at rating: , now: 
New CEO with rationalisation plan; debt is reducing; sale of part of the business (Kier Living) announced; share price has bottomed out due to hedge-fund shorting overshooting the price target -- currently valued at approx one year's earnings and should be 5 or 6 times this value.
| 18:58:33 3 Aug 2019 |
| 12:38:18 17 Apr 2019 |
BUY IMM by
Price at rating: , now:
#IMM #ImmuPharma engages with potential corporate partners for Lupuzor's route to market @ImmuPharma [link] …
| 12:23:10 17 Apr 2019 |
SELL AAOG by
Price at rating: , now:
#AAOG placing coming. need larger cash to make progress. Sefton wont be shy away.
| 13:20:28 8 Apr 2019 |
| 13:19:14 8 Apr 2019 |
| 13:18:27 8 Apr 2019 |
BUY JLP by
Price at rating: , now:
#JLP revenue increased, ebitda increased and applying similar multiple, mcap should be multiple from current level. billionaire and fund managers taking large stake recently. this will rerate ala #BMN
| 13:17:49 8 Apr 2019 |